Join our daily newsletter At The Bell to receive exclusive market insights
EMVision Medical Devices (ASX:EMV) has announced its successful fabrication of a portable on-the-spot brain scanning device.
The First Responder device (FRD) is ultimately like a helmet with a support base meant to be affixed to persons laying on the ground with head injuries in order for a brain scan to be immediately gathered.
In traumatic scenarios, the tech – should it be stocked in ambulances; should it be able to always stay online or connected to nearby clinics or hospitals – could be game changing for obvious reasons.
Notably, EMV is most interested in the application of the FRD in response to strokes.
“The build of our First Responder proof of concept device is the culmination of years of close work with leaders in the pre-hospital sector, including the Australian Stroke Alliance and the Royal Flying Doctor Service, to ensure that we are designing and developing a scalable First Responder solution to broadly transform patient outcomes,” EMV CEO Scott Kirkland said.
“This means creating a device that aims to be economically viable, clinically powerful and attractive for pre-hospital emergency medical services worldwide … core to these requirements is an ultra-light scanner that can be carried in a backpack.”
EMV already has a bedside scanner device called ’emu’, and the FRD has expanded on that build to include 28 antennas internally allowing for a whole-of-brain scan in a single use.
“The device will now be the subject of a series of studies and developments including usability, reliability, software development, functionality and other tests intended to meet international regulatory requirements,” the company wrote on Tuesday.
The device would likely need to satisfy TGA guidelines as if the product was being introduced for the first time.
EMV last traded at $2/sh.
